Your browser doesn't support javascript.
loading
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish, Benjamin H; Quraishi, Mohammed Nabil; Segal, Jonathan P; McCune, Victoria L; Baxter, Melissa; Marsden, Gemma L; Moore, David; Colville, Alaric; Bhala, Neeraj; Iqbal, Tariq H; Settle, Christopher; Kontkowski, Graziella; Hart, Ailsa L; Hawkey, Peter M; Williams, Horace Rt; Goldenberg, Simon D.
Afiliação
  • Mullish BH; Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, Paddington, London, UK.
  • Quraishi MN; Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Segal JP; Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Inflammatory Bowel Disease Unit, St Mark's Hospital, Harrow, London, UK.
  • McCune VL; Public Health England, Public Health Laboratory Birmingham, Birmingham, UK; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Baxter M; Department of Microbiology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Marsden GL; Healthcare Infection Society, London, UK.
  • Moore D; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Colville A; Department of Microbiology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Bhala N; Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Institute of Translational Medicine, University of Birmingham, Edgbaston, Birming
  • Iqbal TH; Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Translational Medicine, University of Birmingham, Edgbaston, Birmingham, UK.
  • Settle C; Department of Microbiology, City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK.
  • Kontkowski G; C diff Support, UK.
  • Hart AL; Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Inflammatory Bowel Disease Unit, St Mark's Hospital, Harrow, London, UK.
  • Hawkey PM; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Williams HR; Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, Paddington, London, UK.
  • Goldenberg SD; Centre for Clinical Infection and Diagnostics Research, King's College London, London, UK; Department of Microbiology, Guy's and St Thomas' NHS Foundation Trust, London UK. Electronic address: simon.goldenberg@gstt.nhs.uk.
J Hosp Infect ; 100 Suppl 1: S1-S31, 2018 09.
Article em En | MEDLINE | ID: mdl-30173851
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Clostridium / Transplante de Microbiota Fecal Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Hosp Infect Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Clostridium / Transplante de Microbiota Fecal Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Hosp Infect Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido